Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid ™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.
Conditions: Rotavirus Infections; Rotavirus Vaccines Interventions: Biological: The pentavalent rotavirus vaccine (live attenuated oral, freeze-dried); Other: Placebo Sponsor: Limited Liability Company Pharm Aid Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy & Immunology | Pharmaceuticals | Research | Rotavirus | Rotavirus Vaccine | Vaccines